Table 1.
Baseline characteristics of subjects.
| HCa | SFTSa | P-value | |
|---|---|---|---|
| Ageb (mean ± SD) | 55.35 ± 10.30 | 59.73 ± 9.03 | 0.13 |
| Male/female | 9/11 | 13/13 | 0.74 |
| ALTc (IQR) | 23.50 (10.25–26.00) | 81.50 (51.00–268.00) | <0.01 |
| ASTc (IQR) | 23.00 (21.00–27.25) | 162.00 (85.50–362.00) | <0.01 |
| LDHc (IQR) | 199.00 (180.50–222.50) | 1159.00 (841.75–2150.00) | <0.01 |
| CKc (IQR) | 80.50 (71.50–107.75) | 234.00 (134.25–838.25) | <0.01 |
aSFTS, severe fever with thrombocytopenia syndrome; HC, health control. bDate are expressed as the mean ± SD, Independent t-test was used to test for significant difference among two groups (P < 0.05). cALT, alanine transaminase, the normal range is 21–72 U/L; AST, aspartate transaminase, the normal range is 17–59 U/L; LDH, lactate dehydrogenase, the normal range is 313–618 U/L; CK, creatine kinase, the normal range is 55–170 U/L. Data are expressed as the Inter-Quartile Range (IQR), Mann–Whitney U test was used to test for significant difference among two groups (P < 0.05).